SCHEMBL9918940

SCHEMBL9918940

C=CCOc1ccc(C)c(N=C=O)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.49
GAA P10253 2/20 0.49
HPGD P15428 2/20 0.49
TRPA1 O75762 1/20 0.49
CYP3A4 P08684 1/20 0.49
CA12 O43570 5/20 0.43
CA1 P00915 5/20 0.43
CA9 Q16790 5/20 0.43
MAPT P10636 2/20 0.42
LMNA P02545 2/20 0.42
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
CA2 P00918 1/20 0.39
CA7 P43166 1/20 0.39
ADRA2A P08913 1/20 0.38
ADRA2B P18089 1/20 0.38
ADRA2C P18825 1/20 0.38
MAOA P21397 1/20 0.38
AGER Q15109 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9918950 0.88 ALDH1A1 (0.46) ALDH1A1GAAHPGDTRPA1CYP3A4
SCHEMBL10433969 0.82 MAPT (0.42) ALDH1A1GAAHPGDCA12CA1
SCHEMBL27762926 0.76 ALDH1A1 (0.53) ALDH1A1GAAHPGDCA12CA1
SCHEMBL29151744 0.75 CYP3A4 (0.44) ALDH1A1GAAHPGDTRPA1CYP3A4
SCHEMBL9050536 0.74 MAPT (0.38) ALDH1A1GAAHPGDTRPA1CYP3A4
SCHEMBL2454654 0.74 CA12 (0.49) ALDH1A1GAAHPGDCYP3A4CA12
SCHEMBL9918951 0.73 CYP3A4 (0.49) ALDH1A1GAAHPGDTRPA1CYP3A4
SCHEMBL9918952 0.73 HPGD (0.39) ALDH1A1GAAHPGDTRPA1CYP3A4
SCHEMBL9918941 0.73 ALDH1A1 (0.43) ALDH1A1GAAHPGDTRPA1CYP3A4
SCHEMBL12005927 0.73 HPGD (0.43) ALDH1A1GAAHPGDCA12CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9334236-B2 Lactam-based compounds with a urethane or urea functional group, and uses thereof ISP INVESTMENTS INC. (US) 2016-05-10 US disclosed
US-9334236-B2 Lactam-based compounds with a urethane or urea functional group, and uses thereof ISP INVESTMENTS INC. (US) 2016-05-10 US disclosed
US-20120149861-A1 LACTAM-BASED COMPOUNDS WITH A URETHANE OR UREA FUNCTIONAL GROUP, AND USES THEREOF ISP INVESTMENTS LLC 2012-06-14 US disclosed
US-20120149861-A1 LACTAM-BASED COMPOUNDS WITH A URETHANE OR UREA FUNCTIONAL GROUP, AND USES THEREOF ISP INVESTMENTS LLC 2012-06-14 US disclosed
WO-2011022457-A1 LACTAM-BASED COMPOUNDS WITH A URETHANE OR UREA FUNCTIONAL GROUP, AND USES THEREOF ISP INVESTMENTS INC. (US) 2011-02-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120149861-A1 LACTAM-BASED COMPOUNDS WITH A URETHANE OR UREA FUNCTIONAL GROUP, AND USES THEREOF CUTA, PUF60, PAM ALDH1A1 1456/4885GAA 3190/4885HPGD 3532/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.